Kari Pekka Pitkänen
Direttore/Membro del Consiglio presso Scellex Oy
Patrimonio netto: 5 M $ in data 30/04/2024
Profilo
Kari Pekka Pitkänen founded Aiforia Technologies Oyj in 2013, where he worked as Director-Business Development from 2021 to 2023.
Mr. Pitkänen also currently works at Scellex Oy, as Director from 2019 and Genna Health Oy, as Director from 2020.
Mr. Pitkänen also formerly worked at Finnzymes Oy, as Marketing Director.
Mr. Pitkänen received his graduate degree from Aalto University School of Science & Technology.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
31/08/2023 | 1 181 000 ( 4.55% ) | 5 M $ | 30/04/2024 |
Posizioni attive di Kari Pekka Pitkänen
Società | Posizione | Inizio |
---|---|---|
Scellex Oy | Direttore/Membro del Consiglio | 01/01/2019 |
Genna Health Oy | Direttore/Membro del Consiglio | 01/01/2020 |
Precedenti posizioni note di Kari Pekka Pitkänen
Società | Posizione | Fine |
---|---|---|
AIFORIA TECHNOLOGIES OYJ | Fondatore | 01/01/2023 |
Finnzymes Oy
Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Vendite & Marketing | - |
Formazione di Kari Pekka Pitkänen
Aalto University School of Science & Technology | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AIFORIA TECHNOLOGIES OYJ | Technology Services |
Aziende private | 3 |
---|---|
Finnzymes Oy
Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Health Technology |
Scellex Oy | |
Genna Health Oy |
- Borsa valori
- Insiders
- Kari Pekka Pitkänen